The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein
Elliott, G., & O'Hare, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81843-7 · Cited by 972
Liposomes as immunological adjuvants
ALLISON, A. C., & GREGORIADIS, G. (1974) · Nature · doi:10.1038/252252a0 · Cited by 675
Fate and behavior of liposomes in vivo: a review of controlling factors.
Senior, J. H. (1987) · PubMed · Cited by 591
Needham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 570
Current status of pH-sensitive liposomes in drug delivery
Drummond, D. C., Zignani, M., & Leroux, J.-C. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00011-4 · Cited by 477
Engineering asymmetric vesicles
Pautot, S., Frisken, B. J., & Weitz, D. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1931005100 · Cited by 470
Chemical Approaches to Triggerable Lipid Vesicles for Drug and Gene Delivery
Guo, X., & Szoka, F. C. (2003) · Accounts of Chemical Research · doi:10.1021/ar9703241 · Cited by 456
pH-Induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact
Ellens, H., Bentz, J., & Szoka, F. C. (1984) · Biochemistry · doi:10.1021/bi00302a029 · Cited by 440
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438
Allen, C., Dos Santos, N., Gallagher, R., Chiu, G. N. C., Shu, Y., Li, W. M., Johnstone, S. A., Janoff, A. S., Mayer, L. D., Webb, M. S., et al. (2002) · Bioscience Reports · doi:10.1023/a:1020186505848 · Cited by 388
Metselaar, J. M., Wauben, M. H. M., Wagenaar‐Hilbers, J. P. A., Boerman, O. C., & Storm, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11140 · Cited by 302
Colletier, J.-P., Chaize, B., Winterhalter, M., & Fournier, D. (2002) · BMC Biotechnology · doi:10.1186/1472-6750-2-9 · Cited by 300
Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time
Lindner, L. H., Eichhorn, M. E., Eibl, H., Teichert, N., Schmitt-Sody, M., Issels, R. D., & Dellian, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0035 · Cited by 258
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes
Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J. E., Collins, L. R., Redemann, C., Martin, F. J., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90194-q · Cited by 241
Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate
Guo, X., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 232
ZUBER, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00213-7 · Cited by 215
Cation Permeability of Phospholipid Model Membranes: Effect of Narcotics
Bangham, A. D., Standish, M. M., & Miller, N. G. A. (1965) · Nature · doi:10.1038/2081295a0 · Cited by 210
Inflexal®V a trivalent virosome subunit influenza vaccine: production
Mischler, R., & Metcalfe, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00512-1 · Cited by 183
Bachmann, M. F., Hengartner, H., & Zinkernagel, R. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251236 · Cited by 176
Gabizon, A., Goren, D., Cohen, R., & Barenholz, Y. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00261-7 · Cited by 170
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies
Schiffelers, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.333 · Cited by 163
Kersten, G. F. A. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00540-6 · Cited by 156
Glück, R., Mischler, R., Brantschen, S., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116141 · Cited by 156
Self-citationPhysicochemical optimisation of plasmid delivery by cationic lipids
Tranchant, I., Thompson, B. J., Nicolazzi, C., Mignet, N., & Scherman, D. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.509 · Cited by 145
Yoshida, J., Mizuno, M., Fujii, M., Kajita, Y., Nakahara, N., Hatano, M., Saito, R., Nobayashi, M., & Wakabayashi, T. (2004) · Human Gene Therapy · doi:10.1089/10430340460732472 · Cited by 131
Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
Sofou, S., Thomas, J. L., Lin, H. Y., McDevitt, M. R., Scheinberg, D. A., & Sgouros, G. (2004) · PubMed · Cited by 119
Abraham, S. A., McKenzie, C., Masin, D., Ng, R., Harasym, T. O., Mayer, L. D., & Bally, M. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1131-03 · Cited by 111
Awasthi, V., Garcia, D., Klipper, R. W., Goins, B., & Phillips, W. T. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060228 · Cited by 101
Zhang, J. X. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.003 · Cited by 95
Efficacy of liposomal budesonide in experimental asthma
Konduri, K. S., Nandedkar, S. D., Düzgüneş, N., Suzara, V. V., Artwohl, J. E., Bunte, R. M., & Gangadharam, P. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.104 · Cited by 95
Zhang, Y., Schlachetzki, F., Li, J. Y., Boado, R. J., & Pardridge, W. M. (2003) · PubMed · Cited by 95
Virosomal adjuvanted antigen delivery systems
Moser, C., Metcalfe, I. C., & Viret, J. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.189 · Cited by 94
Self-citationMueller, M. S., Renard, A., Boato, F., Vogel, D., Martin, N., Zurbriggen, R., Robinson, J. A., & Pluschke, G. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4749-4758.2003 · Cited by 94
Tilcock, C. (1986) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(86)90066-6 · Cited by 92
Immunostimulating reconstituted influenza virosomes
Zurbriggen, R. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00541-8 · Cited by 84
Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model
Jordan, M. B., van Rooijen, N., Izui, S., Kappler, J. W., & Marrack, P. (2002) · Blood · doi:10.1182/blood-2001-11-0061 · Cited by 83
Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner
Hosokawa, S., Tagawa, T., Niki, H., Hirakawa, Y., Nohga, K., & Nagaike, K. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601341 · Cited by 72
Li, W. M., Dragowska, W. H., Bally, M. B., & Schutze-Redelmeier, M.-P. M. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00172-5 · Cited by 69
Erdogan, M., Wright, J. R., & McAlister, V. C. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04800.x · Cited by 68
Bungener, L. B., Huckriede, A. L. W., Wilschut, J., & Daemen, T. (2002) · Bioscience Reports · doi:10.1023/a:1020198908574 · Cited by 66
Kim, J., Choi, S. H., Kim, C.-O., et al. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702928 · Cited by 65
Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation
Schumacher, R., Adamina, M., Zurbriggen, R., Bolli, M., Padovan, E., Zajac, P., Heberer, M., & Spagnoli, G. C. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.08.019 · Cited by 63
Cationic Liposomes as In Vivo Delivery Vehicles
Templeton, N. S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457421 · Cited by 61
Localization of a new neutralizing epitope on the mumps virus hemagglutinin–neuraminidase protein
Cusi, M. G., Fischer, S., Sedlmeier, R., Valassina, M., Valensin, P. E., Donati, M., & Neubert, W. J. (2001) · Virus Research · doi:10.1016/s0168-1702(00)00254-9 · Cited by 60
Huckriede, A. L. W., Bungener, L. B., ter Veer, W., Holtrop, M. E., Daemen, T., Palache, A. M., & Wilschut, J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00542-x · Cited by 60
Targeting her-2/neu with antirat Neu virosomes for cancer therapy.
Waelti, E. R., Wegmann, N., Schwaninger, R., Wetterwald, A., Wingenfeld, C., Rothen‐Rutishauser, B., & Gimmi, C. D. (2002) · PubMed · Cited by 56
Current Status of Delivery Systems to Improve Target Efficacy of Oligonu-cleotides
Shôji, Y., & Nakashima, H. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453009 · Cited by 52
IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization
Zurbriggen, R., Novak‐Hofer, I., Seelig, A., & Glück, R. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(99)00017-x · Cited by 52
Self-citationBrignole, C., Pagnan, G., Marimpietri, D., Cosimo, E., Allen, T. M., Ponzoni, M., & Pastorino, F. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00107-1 · Cited by 48
Some negatively charged phospholipid derivatives prolong the liposome circulation in vivo
Park, Y. S., Maruyama, K., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90034-j · Cited by 44
Tat Peptide-Mediated Intracellular Delivery of Liposomes
Levchenko, T. S., Rammohan, R., Volodina, N., & Torchilin, V. P. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)72019-9 · Cited by 41
Cusi, M. G., Zurbriggen, R., Correale, P., Valassina, M., Terrosi, C., Pergola, L., Valensin, P. E., & Glück, R. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00353-5 · Cited by 40
Self-citationWaterhouse, D., Dragowska, W. H., Gelmon, K. A., Mayer, L. D., & Bally, M. B. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.622 · Cited by 36
Targeting influenza virosomes to ovarian carcinoma cells
Mastrobattista, E., Schoen, P., Wilschut, J., Crommelin, D. J. A., & Storm, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03112-x · Cited by 29
Shoji, J., Tanihara, Y., Uchiyama, T., & Kawai, A. (2004) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2004.tb03502.x · Cited by 28
Schmidt, J., Metselaar, J. M., & Gold, R. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100915 · Cited by 28
Alvarez, M. J., Echechipia, S., García, B. E., et al. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01514.x · Cited by 27
Park, C., Thiex, N. W., Lee, K., Szot, G. L., Bluestone, J. A., & Lee, K.-D. (2003) · Pharmaceutical Research · doi:10.1023/a:1025057216492 · Cited by 20
Kanaoka, E., Takahashi, K., Yoshikawa, T., et al. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120025872 · Cited by 18
Enhanced cytotoxicity of doxorubicin encapsulated in liposomes with reconstituted Sendai F-proteins
Cho, H. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010019550 · Cited by 8
Cited by
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
The forthcoming applications of gold nanoparticles in drug and gene delivery systems
Pissuwan, D., Niidome, T., & Cortie, M. B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.006 · Cited by 669
Nakhaei, P., Margiana, R., Bokov, D. O., Abdelbasset, W. K., Jadidi Kouhbanani, M. A., Varma, R. S., Marofi, F., Jarahian, M., & Beheshtkhoo, N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.705886 · Cited by 479
RetractedApplication of Various Types of Liposomes in Drug Delivery Systems
Alavi, M., Karimi, N., & Safaei, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.002 · Cited by 466
Gene therapy and DNA delivery systems
Ibraheem, D., Elaissari, A., & Fessi, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.041 · Cited by 454
Metadata
- Authors
- Felnerova, D., Viret, J.-F., Glück, R., & Moser, C.
- Venue
- Current Opinion in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 15
- Issue
- 6
- Pages
- 518-529
- ISSN
- 0958-1669 (ISSN-L)
- OpenAlex
- W2076403509
- Cited by
- 296
- References
- 60
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.